Bodycad’s board of advisors understands the need for personalized orthopaedics. The advisors are passionate about the practice of medicine and orthopaedic research which plays a critical role in evolving orthopaedic care. These seasoned professionals provide real-world perspectives to the company and help make personalized restorations a reality.
Daniel J. Berry
Chief Science Advisor
Dr. Daniel J. Berry, M.D. is a past President of the American Academy of Orthopaedic Surgeons. Dr. Berry was appointed to the Staff of Mayo Clinic, 1991; specialty in complex and revision hip and knee surgery. He became chairman of the Mayo Department of Orthopedic Surgery, 2005-2014; and named as L.Z. Gund Professor of Orthopedic Surgery. Dr. Berry has served on numerous committees and task forces, including the American Joint Replacement Registry (AJRR) and the CME Courses Committee. He has also served as president of the American Association of Hip and Knee Surgeons (AAHKS) and held previous leadership roles for the American Board of Orthopaedic Surgery (ABOS), the Hip Society and the Mid America Orthopaedic Association. He serves as a Trustee of The Journal of Bone and Joint Surgery, Inc. He has been Trustee of Mayo Clinic since 2013. An orthopaedic researcher, Dr. Berry has received numerous honors and accolades including awards for clinical research from the Hip Society, the Knee Society, the AAHKS, and the Orthopedic Research and Education Foundation (OREF). He serves as professor of orthopaedics, College of Medicine at Mayo Clinic. He is the author of more than 190 peer reviewed publications and 70 book chapters and has been the editor of several books on hip and knee arthroplasty He has made scientific presentations at hundreds of regional, national and international meetings. A graduate of Dartmouth College and Harvard Medical School, Dr. Berry completed orthopaedic surgery residencies at Harvard, Brigham and Women's Hospital and Massachusetts General Hospital. He completed his fellowship at Mayo Clinic in Rochester, Minnesota.
Dr. Étienne Belzile is an Assistant Professor at Université Laval, in Quebec City, Canada. He received his medical degree from McGill University and completed orthopaedic residency at Université Laval. He completed a fellowship in hip and knee adult reconstruction at the University of Virginia, as well as in pelvic reconstruction in young adults and adolescents at Harvard University. He serves on the Board of Directors of the Canadian Orthopaedic Foundation. He is also the Chairman of the Scientific Program 2016 of the Canadian Orthopaedic Association (COA) meeting in Quebec City and was the Co-chairman of the COA Program Committee in 2013-2014 and of the AOA/COA Combined Meeting who took place in Montreal. In 2013, he acted as the co-host of the 10th Symposium on Joint Preserving and Minimally Invasive Surgery of the Hip. Furthermore, he is a member of the EPCAT II Study Steering Committee (CIHR funded) and serves as Director of Clinical Research, Orthopaedic Surgery Service, CHUQ, Quebec. He has published several articles and made various presentations on hip joint preservation surgery. His gamut of practice includes hip arthroscopy, hip resurfacing, PAO, surgical dislocation, and DAA THR.
Dr. Brian Hamlin is a board-certified orthopaedic surgeon and Associate Director of the Bone and Joint Center of Magee-Womens Hospital of UPMC. He specializes in the treatment of diseases of the hip and knee. Dr. Hamlin has a developed expertise in the use of computer-assisted surgical systems, and advanced robotic surgical systems for treatment of unicompartmental knee replacement. Dr. Hamlin has published and presented numerous research projects in relation to the advancement of knowledge in the field of joint replacement including examination of new technologies, minimally invasive procedures, and long-term survivorship of implants. He has been recognized nationally as a Leadership Fellow with the American Academy of Orthopaedic Surgeons and is a member of the American Orthopaedic Association. He is a Fellow of the American Academy of Orthopaedic Surgeons and a member of American Association of Hip and Knee Surgeons. Dr. Hamlin is a graduate of Washington and Jefferson College, and The University of Texas-Southwestern Medical School at Dallas. Dr. Hamlin completed his internship and residency training in orthopaedic surgery at the Mayo Clinic in Rochester, MN. After his military obligation, he pursued a fellowship in Adult Reconstruction at Virginia Commonwealth University School of Medicine.
Dr. Nicolas Duval first graduated in 1989 as an orthopaedic surgeon from Université Laval, Quebec City. He then furthered his education with a subspeciality in reconstruction of the adult hip and knee at Western University, London, Ontario. He also obtained a degree in Physical Activity Sciences from Université Laval.
Dr. Duval specializes in problems related to the adult hip and knee. He has worked in Quebec’s public health system for thirteen years. After two years in the Lac-Saint-Jean region, at the Alma hospital center, he relocated to Montreal and he practiced successively at the Queen Elizabeth Hospital (affiliated to McGill University), the Notre-Dame Hospital, and the Saint-Luc Hospital—CHUM (both affiliated to Université de Montréal). Dr. Duval is very active in scientific research and has published fundamental research and clinical research articles.
As of January 2002, Dr. Duval has been the very first orthopaedic surgeon to be in private practice in Canada as a non-participating professional to the Régie de l’assurance maladie du Québec. He is co-founder of the Duval Orthopaedic Clinic located in the City of Laval, in the province of Quebec, where he has been practicing full time since 2003.
Dr. Michèle Angers is an Assistant Professor at Université Laval, in Quebec City, Canada. She received her medical degree and completed her orthopaedic residency program at Université Laval. She completed a fellowship in hip and knee adult reconstruction at the University of California – San Francisco. Dr. Angers is an active member of Canada’s and Quebec’s orthopaedic associations. She has made several clinical publications and presentations on adult reconstruction with an emphasis on bone mineral density. She has presented at a number of international meetings, including for the International Society for Technology in Arthroplasty (ISTA), the Société française de chirurgie orthopédique et traumatologique (SOFCOT), the International Congress for Joint Reconstruction (ICJR), as well as the American Academy of Orthopaedic Surgeons (AAOS). Her practice primarily includes complex and primary adult reconstructions.
Robert A. Poggie
Research and Regulatory Advisor
Bob has worked in the orthopaedic industry since 1992, with experience and responsibilities in applied in research, clinical affairs, regulatory affairs, and medical education. Bob was instrumental in the research and development of Smith & Nephew’s Oxynium Technology and Zimmer’s Trabecular Metal technology, and continues to be engaged in the applied research and regulatory approval of new orthopaedic products. Since 2009, Bob has been an independent consultant (BioVera Inc., Notre-Dame-de-L’Ile-Perrot, Quebec, Canada) to the industry for strategy and execution of commercialization of new orthopaedic devices. Prior to BioVera, Bob was Director of Global Brand Management for Zimmer Trabecular Metal Technology, Inc. Bob coordinated and/or authored the publication of pre-clinical and clinical studies of orthopedic implants, biomaterials, surgical protocols, and product literature. He wrote the FDA and international submissions that resulted in numerous regulatory clearances for spinal, hip, knee, and shoulder products, and created the training materials for prospective surgeon users and the company’s sales associates. Prior to Zimmer, Bob was Director of Applied Research for Implex Corp. the original developer of Trabecular Metal technology. Bob managed the research, the lab and university testing, and the worldwide regulatory clearances of all the orthopedic products. He initiated and managed FDA regulated investigational studies, which included the recruitment of surgeon investigators, clinical site data compilation, and publication results. Prior to Implex, Bob was a senior research engineer for Smith & Nephew, responsible for metallurgical and tribological research, which included Oxynium technology. Bob has published numerous peer reviewed papers and presented globally as invited faculty at over 100 medical conferences and education courses. He is a member of several professional engineering and medical societies, and holds a BE in Mechanical Engineering and MS and PhD degrees in Materials Science & Engineering, all from Vanderbilt University in Nashville, TN.